Relationship Between UGT1A4 and UGT2B7 Polymorphisms and the Steady-State Plasma Concentrations of Lamotrigine in Patients With Treatment-Resistant Depressive Disorder Receiving Lamotrigine as Augmentation Therapy-Reference-Cited by-同舟云学术

Relationship Between UGT1A4 and UGT2B7 Polymorphisms and the Steady-State Plasma Concentrations of Lamotrigine in Patients With Treatment-Resistant Depressive Disorder Receiving Lamotrigine as Augmentation Therapy

Published:2019-02 Issue:1 Volume:41 Page:86-90
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Suzuki Takeshi,Mihara Kazuo,Nagai Goyo,Kagawa Shoko,Nakamura Akifumi,Nemoto Kenji,Kondo Tsuyoshi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference13 articles.

1. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomized trials;Geddes;Br J Psychiatry.,2009

2. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials;Solmi;CNS Spectr.,2016

3. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability;Ivković;Psychiatr Danub.,2009

4. Lamotrigine augmentation for the treatment-resistant mood disorder;Kagawa;Clin Neuropsychopharmacol Ther,2010

5. Relationship between plasma concentrations of lamotrigine and its early therapeutic effect of lamotrigine augmentation therapy in treatment-resistant depressive disorder;Kagawa;Ther Drug Monit.,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of UGT1A4 and UGT2B7 polymorphisms on lamotrigine plasma concentration in patients with bipolar disorder;Pharmacogenetics and Genomics;2024-08-23

2. Effect of Genetic Polymorphisms of ABCB1, ABCG2, and SLC22A1 on the Steady-State Plasma Concentrations of Lamotrigine in Treatment-Resistant Depressed Patients Treated With Lamotrigine Augmentation Therapy;Clinical Neuropharmacology;2024-08-20

3. Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs;JAMA Network Open;2024-08-08

4. UGT1A4*3 polymorphism influences serum concentration and therapeutic effect of lamotrigine for epilepsy treatment: A meta-analysis;PLOS ONE;2024-07-18

5. Pharmacokinetic Simulation Study: Exploring the Impact of Clinical Parameters on Lamotrigine for Different Patient Populations with Implications for Liver Function Assessment and Therapeutic Drug Monitoring;Scientia Pharmaceutica;2024-02-28